US Stock MarketDetailed Quotes

YMAB Y-mAbs Therapeutics

Watchlist

11.920
+0.040+0.34%

Close Nov 29 13:00 ET

11.920
0.0000.00%

Post 13:02 ET

533.89MMarket Cap-22074P/E (TTM)

Y-mAbs Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Total revenue

-9.74%18.46M

9.86%22.8M

-1.58%19.93M

29.96%84.82M

-25.71%23.36M

63.15%20.45M

92.19%20.75M

93.12%20.25M

87.03%65.27M

227.64%31.45M

Operating revenue

-9.74%18.46M

9.86%22.8M

-1.58%19.93M

29.96%84.82M

-25.71%23.36M

63.15%20.45M

92.19%20.75M

93.12%20.25M

87.03%65.27M

227.64%31.45M

Cost of revenue

-15.01%2.25M

-35.17%3.01M

3.07%2.15M

50.87%11.42M

0.94%2.04M

6.87%2.65M

274.92%4.65M

13.76%2.08M

200.99%7.57M

38.26%2.02M

Gross profit

-8.96%16.21M

22.87%19.78M

-2.11%17.78M

27.21%73.4M

-27.54%21.32M

76.99%17.81M

68.48%16.1M

109.91%18.17M

78.18%57.7M

261.64%29.43M

Operating expense

-3.04%24.78M

26.79%29.57M

-3.81%24.69M

-35.04%99.08M

-19.81%24.52M

-29.16%25.56M

-52.88%23.33M

-29.38%25.67M

3.18%152.51M

-30.33%30.58M

Selling and administrative expenses

33.46%13.61M

52.90%17.23M

-6.74%11.43M

-26.39%44.86M

3.17%11.14M

-25.14%10.2M

-51.17%11.27M

-8.83%12.25M

11.67%60.94M

-28.70%10.79M

Research and development costs

-27.28%11.17M

2.37%12.34M

-1.13%13.27M

-40.79%54.22M

-32.34%13.39M

-31.60%15.36M

-54.37%12.06M

-41.44%13.42M

-1.79%91.57M

-31.19%19.79M

Operating profit

-10.57%-8.57M

-35.53%-9.79M

7.91%-6.91M

72.92%-25.67M

-177.45%-3.2M

70.22%-7.75M

81.92%-7.22M

72.92%-7.5M

17.86%-94.81M

96.78%-1.15M

Net non-operating interest income expense

913.76%1.92M

-41.82%640K

-60.49%439K

734.87%4.81M

4.16%2.41M

112.52%189K

192.75%1.1M

397.86%1.11M

59.13%-757K

303.52%2.31M

Non-operating interest income

913.76%1.92M

-41.82%640K

-60.49%439K

----

--189K

--1.1M

--1.11M

----

Total other finance cost

----

-734.87%-4.81M

----

--757K

----

Other net income (expense)

Income before tax

12.01%-6.65M

-49.42%-9.15M

-1.24%-6.47M

78.17%-20.87M

-168.54%-793K

72.54%-7.56M

85.11%-6.12M

77.23%-6.39M

-72.90%-95.57M

103.14%1.16M

Income tax

85.03%346K

-44.13%100K

160K

561K

195K

187K

179K

Net income

9.67%-7M

-46.76%-9.25M

-3.74%-6.63M

77.58%-21.43M

-185.39%-988K

71.86%-7.75M

84.68%-6.3M

77.23%-6.39M

-72.90%-95.57M

103.14%1.16M

Net income continuous Operations

9.67%-7M

-46.76%-9.25M

-3.74%-6.63M

77.58%-21.43M

-185.39%-988K

71.86%-7.75M

84.68%-6.3M

77.23%-6.39M

-72.90%-95.57M

103.14%1.16M

Minority interest income

Net income attributable to the parent company

9.67%-7M

-46.76%-9.25M

-3.74%-6.63M

77.58%-21.43M

-185.39%-988K

71.86%-7.75M

84.68%-6.3M

77.23%-6.39M

-72.90%-95.57M

103.14%1.16M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

9.67%-7M

-46.76%-9.25M

-3.74%-6.63M

77.58%-21.43M

-185.39%-988K

71.86%-7.75M

84.68%-6.3M

77.23%-6.39M

-72.90%-95.57M

103.14%1.16M

Basic earnings per share

11.11%-0.16

-50.00%-0.21

0.00%-0.15

77.63%-0.49

-166.67%-0.02

71.43%-0.18

85.11%-0.14

76.56%-0.15

-71.09%-2.19

103.53%0.03

Diluted earnings per share

11.11%-0.16

-50.00%-0.21

0.00%-0.15

77.63%-0.49

-166.67%-0.02

71.43%-0.18

85.11%-0.14

76.56%-0.15

-71.09%-2.19

103.53%0.03

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Total revenue	-9.74%18.46M	9.86%22.8M	-1.58%19.93M	29.96%84.82M	-25.71%23.36M	63.15%20.45M	92.19%20.75M	93.12%20.25M	87.03%65.27M	227.64%31.45M
Operating revenue	-9.74%18.46M	9.86%22.8M	-1.58%19.93M	29.96%84.82M	-25.71%23.36M	63.15%20.45M	92.19%20.75M	93.12%20.25M	87.03%65.27M	227.64%31.45M
Cost of revenue	-15.01%2.25M	-35.17%3.01M	3.07%2.15M	50.87%11.42M	0.94%2.04M	6.87%2.65M	274.92%4.65M	13.76%2.08M	200.99%7.57M	38.26%2.02M
Gross profit	-8.96%16.21M	22.87%19.78M	-2.11%17.78M	27.21%73.4M	-27.54%21.32M	76.99%17.81M	68.48%16.1M	109.91%18.17M	78.18%57.7M	261.64%29.43M
Operating expense	-3.04%24.78M	26.79%29.57M	-3.81%24.69M	-35.04%99.08M	-19.81%24.52M	-29.16%25.56M	-52.88%23.33M	-29.38%25.67M	3.18%152.51M	-30.33%30.58M
Selling and administrative expenses	33.46%13.61M	52.90%17.23M	-6.74%11.43M	-26.39%44.86M	3.17%11.14M	-25.14%10.2M	-51.17%11.27M	-8.83%12.25M	11.67%60.94M	-28.70%10.79M
Research and development costs	-27.28%11.17M	2.37%12.34M	-1.13%13.27M	-40.79%54.22M	-32.34%13.39M	-31.60%15.36M	-54.37%12.06M	-41.44%13.42M	-1.79%91.57M	-31.19%19.79M
Operating profit	-10.57%-8.57M	-35.53%-9.79M	7.91%-6.91M	72.92%-25.67M	-177.45%-3.2M	70.22%-7.75M	81.92%-7.22M	72.92%-7.5M	17.86%-94.81M	96.78%-1.15M
Net non-operating interest income expense	913.76%1.92M	-41.82%640K	-60.49%439K	734.87%4.81M	4.16%2.41M	112.52%189K	192.75%1.1M	397.86%1.11M	59.13%-757K	303.52%2.31M
Non-operating interest income	913.76%1.92M	-41.82%640K	-60.49%439K	----	----	--189K	--1.1M	--1.11M	----	----
Total other finance cost	----	----	----	-734.87%-4.81M	----	----	----	----	--757K	----
Other net income (expense)
Income before tax	12.01%-6.65M	-49.42%-9.15M	-1.24%-6.47M	78.17%-20.87M	-168.54%-793K	72.54%-7.56M	85.11%-6.12M	77.23%-6.39M	-72.90%-95.57M	103.14%1.16M
Income tax	85.03%346K	-44.13%100K	160K	561K	195K	187K	179K	0	0	0
Net income	9.67%-7M	-46.76%-9.25M	-3.74%-6.63M	77.58%-21.43M	-185.39%-988K	71.86%-7.75M	84.68%-6.3M	77.23%-6.39M	-72.90%-95.57M	103.14%1.16M
Net income continuous Operations	9.67%-7M	-46.76%-9.25M	-3.74%-6.63M	77.58%-21.43M	-185.39%-988K	71.86%-7.75M	84.68%-6.3M	77.23%-6.39M	-72.90%-95.57M	103.14%1.16M
Minority interest income
Net income attributable to the parent company	9.67%-7M	-46.76%-9.25M	-3.74%-6.63M	77.58%-21.43M	-185.39%-988K	71.86%-7.75M	84.68%-6.3M	77.23%-6.39M	-72.90%-95.57M	103.14%1.16M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	9.67%-7M	-46.76%-9.25M	-3.74%-6.63M	77.58%-21.43M	-185.39%-988K	71.86%-7.75M	84.68%-6.3M	77.23%-6.39M	-72.90%-95.57M	103.14%1.16M
Basic earnings per share	11.11%-0.16	-50.00%-0.21	0.00%-0.15	77.63%-0.49	-166.67%-0.02	71.43%-0.18	85.11%-0.14	76.56%-0.15	-71.09%-2.19	103.53%0.03
Diluted earnings per share	11.11%-0.16	-50.00%-0.21	0.00%-0.15	77.63%-0.49	-166.67%-0.02	71.43%-0.18	85.11%-0.14	76.56%-0.15	-71.09%-2.19	103.53%0.03
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data